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Abstract: Objectives: Positron emission tomography (PET) and volume of interest (VOI) analysis have
recently shown in amyotrophic lateral sclerosis (ALS) an accuracy of 93% in differentiating patients
from controls. The aim of this study was to disclose by spatial independent component analysis (ICA)
the brain networks involved in ALS pathological processes and evaluate their discriminative value in
separating patients from controls. Experimental design: Two hundred fifty-nine ALS patients and 40
age- and sex-matched control subjects underwent brain 18F-2-fluoro-2-deoxy-D-glucose PET (FDG-
PET). Spatial ICA of the preprocessed FDG-PET images was performed. Intensity values were con-
verted to z-scores and binary masks were used as data-driven VOIs. The accuracy of this classifier was
tested versus a validated system processing intensity signals in 27 brain meta-VOIs. A support vector
machine was independently applied to both datasets and the ‘leave-one-out’ technique verified the
general validity of results. Principal observations: The 8 components selected as pathophysiologically
meaningful discriminated patients from controls with 99.0% accuracy, the discriminating value of
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bilateral cerebellum/midbrain alone representing 96.3%. Among the meta-VOIs, right temporal lobe
alone reached an accuracy of 93.7%. Conclusions: Spatial ICA identified in a very large cohort of ALS
patients distinct spatial networks showing a high discriminatory value, improving substantially on the
previously obtained accuracy. The cerebellar/midbrain component accounted for the highest accuracy
in separating ALS patients from controls. Spatial ICA and multivariate analysis perform better
than univariate semi-quantification methods in identifying the neurodegenerative features of ALS and
pave the way for inclusion of PET in clinical trials and early diagnosis. Hum Brain Mapp 37:942–953,
2016. VC 2015 Wiley Periodicals, Inc.
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INTRODUCTION
Amyotrophic lateral sclerosis (ALS) is a neurodegenera-
tive disease characterized by a progressive muscle paraly-
sis associated with degeneration of motor neurons in the
primary motor cortex, brainstem, and spinal cord [Chio
et al., 2014], with an incidence of 2-3/100,000 new cases
per year [Chio et al., 2013]. Two-thirds of patients present
with spinal onset (hypotrophy and weakness of upper or
lower limb muscles), one-third with bulbar onset (dyspha-
gia and dysarthria). In the latter group, a moderate-to-
severe impairment of frontal lobe functions occurs in a
variable percentage of cases [Abrahams et al., 2005; Quar-
tuccio et al., 2014].
The diagnosis of ALS remains largely based on the dem-
onstration of the involvement of upper and lower motor
neurons, associated with a relentlessly progressive course.
In the diagnostic work-up and to differentiate ALS from
mimicking diseases, brain positron emission tomography
(PET) could represent a valuable tool and various radio-
pharmaceuticals have been used to assess changes in
regions affected by ALS [Corcia et al., 2012; Johansson
et al., 2007; Lloyd et al., 2000; Turner et al., 2004].
Most of the PET studies in ALS have been performed
using 18F-2-fluoro-2-deoxy-D-glucose (FDG-PET), recruit-
ing normal subjects as a control group and looking for
ALS-related metabolic patterns. Patients with ALS usually
demonstrate a decreased [18F]FDG uptake in primary and
supplementary motor, premotor and frontal cortices,
as well as clusters of relative hypermetabolism in the corti-
cospinal white matter tracts, mesiotemporal regions, cere-
bellum, and upper brain stem, reflecting a complex
pathophysiology involving degeneration of gray matter
and areas of reactive glial activation [Braak et al., 2013;
Chio et al., 2014; Cistaro et al., 2012].
The potential of FDG-PET as an important biomarker
for ALS diagnosis has been recently confirmed by two
investigations in rather large cohorts [Pagani et al., 2014;
Van Laere et al., 2014]. Both studies showed FDG-PET in
ALS to have a diagnostic accuracy of over 90% in separat-
ing patients from controls and confirmed a mixed
hypometabolic-hypermetabolic pattern.
The majority of the above-mentioned studies were
largely based on univariate linear models in which voxels
or regions of interest were analyzed independently of each
other, but the high accuracy obtained by discriminant
analysis, also involving nonlinear techniques, highlighted
the potential of a multivariate approach [Pagani et al.,
2014; Van Laere et al., 2014].
A recent study reported both structural MRI and FDG-
PET voxel-based analyses in a limited number of patients
with ALS and fronto-temporal dementia. Gray matter vol-
ume reduction was mainly due to cortical thinning rather
than to reduced brain volume and this was paralleled by
concomitant glucose hypometabolism. However, isolated
changes at FDG PET were detected in motor and extramo-
tor regions suggesting that functional abnormalities of
gray matter may precede cortical atrophy [Rajagopalan
and Pioro, 2015].
In brain disorders, analyses of cross-sectional data of
multiple images aim at disclosing the characteristic pat-
terns of pathophysiological changes. FDG-PET reflects
changes in synaptic activity in the brain: correlated meta-
bolic changes in specific brain regions might provide an
index of neuropathological processes.
Spatial functional networks delineating coherent interre-
gional spontaneous fluctuations in different brain areas
have been investigated mainly by functional magnetic res-
onance imaging (fMRI). In this respect, coactivation of spa-
tially disparate brain regions is well captured by
independent component analysis (ICA), a data-driven
technique blindly separating mixed signals into independ-
ent sources. ICA does not require any initial topographic
assumption and intrinsically determines distinct compo-
nents by dividing the image data into spatially independ-
ent activation maps without the need of seed regions
[Margulies et al., 2010].
Connectivity analyses have been performed in ALS by
diffusion tensor imaging (DTI) and resting state fMRI
[Douaud et al., 2011; Verstraete et al., 2010] with findings
of white matter tract changes associated to cortical ones
[Douaud et al., 2011]. ICA also showed, by fMRI, changes
in the default mode network (DMN) [Mohammadi et al.,
2009]. More recently, Welsh et al. [2013] utilized a support
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vector machine applied to fMRI data to discriminate ALS
patients and controls by ICA-derived networks, achieving
an accuracy of 71% and revealing the DMN and motor
network as the main discriminant components.
However, to date no connectivity analysis has been
performed in ALS patients by PET, although some stud-
ies have suggested that ICA could be applied to a series
of PET images, one image per subject or recording condi-
tion, in order to disclose brain networks involved in
physiological and pathological processes [Gray et al.,
2012; Park et al., 2003]. The aim of this study was to iden-
tify covariant spatial patterns by ICA in resting state
FDG-PET derived from a large sample of ALS patients
and to test their accuracy in discriminating patients from
healthy controls. The results were compared in the same
groups of subjects to those obtained with a more conven-
tional volume-of-interest (VOI)-based discriminant
analysis.
MATERIALS AND METHODS
We performed FDG-PET in 259 ALS patients (mean age
63.36 11.8 years, range 21–86; females 107/259) referred to
the Turin ALS center and prospectively recruited between
June 2011 and February 2014. Diagnoses of laboratory-
supported probable, probable, or definite ALS were made
according to El Escorial ALS revised criteria [Brooks et al.,
2000]. Most patients underwent FDG-PET within 5 months
of diagnosis. Median time between disease onset and PET
examination was 15.3 months.
According to the clinical presentation at the time of the
PET scan, 165 patients were diagnosed as spinal (mean
age 61.96 12.4 years, range 21–86; females 52/165) and 94
as bulbar (mean age 65.66 10.2 years, range 40–82; females
55/94). To be classified in the bulbar group, patients with
bulbar symptoms had to have less than 4 points loss on
the spinal domain of the ALSFRS-R scale (items 4 to 12).
The mean disease duration was 156 12.4 months, range
2–76; mean ALS-FRS score was 39.36 6.4, range 10–48.
Seventeen patients were carrying the C9ORF72 mutation.
The control group was composed of 40 subjects (mean
age 626 14.4 years, range 27–84; females 11/40) under-
going FDG-PET due to suspected diagnosis of lung cancer,
but in which no abnormal metabolism was found in any
body or brain region. All subjects had normal neurological
assessment and the exclusion criteria were the same as
applied in studies of other neurodegenerative disorders:
presence of major systemic illness, major vision disturban-
ces, psychiatric illnesses, and diseases impacting on brain
functioning and metabolism [Nobili et al., 2010; Pagani
et al., 2010].
The study design was approved by the institutional
ethics committee in compliance with the Code of Ethics
of the World Medical Association (Declaration of Hel-
sinki). Patients and controls signed written informed
consent.
Image Acquisition and Preprocessing
FDG-PET examinations were performed following cur-
rent guidelines [Varrone et al., 2009]. PET/computerized
tomography (CT) brain scans were acquired by a Discov-
ery ST-E System (General Electric) in two sequential scans:
PET scan (1 FOV of 30 transaxial cm) was initiated imme-
diately after CT (thickness of 3.75 mm, 140 kVolt, 60–80
mA/s) used for attenuation correction of PET data. Data
were collected in 128 3 128 matrices with a reconstructed
voxel of 2.34 x 2.34 x 2.00 mm.
PET scans were normalized using a customized brain
FDG-PET template, obtained using FDG-PET scans from a
group of healthy subjects performed at the same center.
Template editing was performed according to published
procedures [Morbelli et al., 2012]. The spatially normalized
PET images were further normalized to the average of the
brain voxels with the highest 20% of intensity and
smoothed with an 8 mm isotropic Gaussian filter, an ideal
parameter for favoring in PET pooled analyses the optimal
detectability of separated spatial signals [Woods, 1996].
Statistical Analyses
Independent component analysis (ICA)
ICA models observe data as a linear combination of a
set of statistically independent components having non-
Gaussian (mainly sparse) distribution [Brown et al., 2001].
In the analysis of neuroimages, ICA results in spatial com-
ponents representing metabolic networks varying coher-
ently across subjects, the distribution of voxels in each
component being statistically independent of the distribu-
tion in other components [McKeown et al., 1998]. This
approach enforces the delineation of borders between pos-
sibly overlying networks [Kalcher et al., 2012].
Spatial ICA of the preprocessed FDG-PET images was
performed using the GIFT toolbox (http://mialab.mrn.
org/software/). Image data from each subject were
arranged in a sequence and were whitened and reduced
by principal component analysis (PCA). Then an Infomax
ICA algorithm, minimizing the mutual information, was
used to estimate the independent spatial components (ICs)
[Bell and Sejnowski, 1995; Brown et al., 2001]. The basic
assumption of the infomax algorithm is that the underly-
ing sources are sparsely distributed, i.e. the distribution of
each source is super-Gaussian [Park et al., 2003]. The opti-
mal number of components was determined from the data
using the GIFT dimensionality estimation tool, this num-
ber representing a good tradeoff between the preservation
of the information intrinsically contained in the data and
the reduction of its size. To display the voxels that most
contributed to the resulting spatial maps, intensity values
in each of them were converted to z-scores and image val-
ues were visualized using a threshold of z5 1.96 creating
binary masks. From the resulting components, those with
either pathophysiological or anatomo-functional meaning
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were selected and each component was named according
to its anatomy.
The masks were then used as data-driven VOIs. ICA
was applied to the series of ALS patients in order to dis-
close brain networks affected by pathological processes as
well as components which are supposedly shared with
healthy subjects. The resulting transformation matrix was
then applied to compute these components for each sub-
ject in the whole group in order to compare patients and
controls by ICA-based discriminant analysis. This
approach is in agreement with the one-class-classification
model, constructed to describe a reference group and
where differences, or ‘novelities’, are detected as devia-
tions from this model [Tax and Duin, 1999]. One-class-
classification is particularly suitable for datasets in which a
very well-sampled reference group with a large number of
samples is compared to an undersampled alternative
group. In the present study, the number of ALS patients
far exceeded that of normal controls and we could con-
sider ALS as the reference group in order to explore inde-
pendent components as one-class descriptors and to verify
how well these descriptors could perform in two-class dis-
criminant analysis.
Region of interest identification and
data preprocessing
In order to test the ICA-based classifier versus an
already validated system, we analyzed the FDG-PET data
of both ALS patients and controls by an in-house created
Matlab-based script [Pagani et al., 2015] that automatically
extracted and processed mean relative FDG uptake signals
intensity in 45 anatomical volumes of interest (VOIs) in
each hemisphere (90 VOIs) as identified by the Automated
Anatomical Labelling (AAL) Atlas [Tzourio-Mazoyer et al.,
2002]. In order to reduce the number of variables and to
verify to what extent the analysis of specific and function-
ally meaningful regions could provide information about
pathological processes, based on a priori criteria we
merged regions with similar anatomo-functional character-
istics into meta-VOIs [Pagani et al., 2015].
Twelve meta-VOIs were constructed in each
hemisphere:
1. Occipital cortex (calcarine/lingual/inferior occipi-
tal/middle occipital/superior occipital gyri);
2. Putamen/pallidum/caudate;
3. Parahippocampal gyrus/amygdala/hippocampus/
insula;
4. Orbito-frontal cortex (inferior frontal/medial fron-
tal/superior-orbital frontal gyri);
5. Frontal cortex (middle frontal/superior frontal/
superior-medial frontal gyri);
6. Cuneus/fusiform gyrus/precuneus;
7. Postcentral/precentral gyri/supplementary motor
area;
8. Parietal lobe (inferior parietal/superior parietal
gyri);
9. Anterior cingulate gyrus;
10. Posterior cingulate gyrus;
11. Temporal lobe (inferior temporal/middle temporal/
superior temporal gyri), and
12. Temporal pole (middle temporal pole/superior tem-
poral pole gyri).
Since in previous investigations on a sub-group of the
present ALS patient sample an involvement of the cerebel-
lum was found [Cistaro et al., 2014; Pagani et al., 2014],
we added into the dataset three further VOIs, the two cer-
ebellar hemispheres, separately, and the cerebellar vermis,
and they were included in the discriminant analysis.
Discriminant analysis (DA)
DA was performed by a non-linear classifier based on
the support vector machine (SVM) method with radial
basis functions [Cortes and Vapnik, 1995] in order to dis-
criminate ALS patients and controls based on FDG-PET.
PET data were preprocessed by ICA and by meta-VOI,
producing two different datasets. DA was independently
applied to the two datasets (ICA-based and meta-VOI-
based) drawn from the same groups of PET images in
order to evaluate the influence of the feature extraction
method and to identify the regions or networks with the
highest discriminatory value.
The discrimination based on each dataset was followed
by the application of a stepwise backward selection proce-
dure in which the least influential variable was removed
and replaced by the best variable (if any) at each step. The
effectiveness of the discrimination was evaluated by
‘leave-one-out’ cross-validation by which each subject was
classified using a model fitted to all the remaining ones.
Cross-validation was adopted in order to verify the gen-
eral validity of results and to prevent accuracy overrating
due to overfitting, i.e. an excessive adaptation to the char-
acteristics of the study sample.
Receiver operating characteristic (ROC) curves and area
under the curve (AUC) were computed at each classifica-
tion step and relevant confidence intervals were estimated
by the bootstrap method described by Qin and Hotilovac
[2008]. For a comparison between the results obtained with
two different procedures, the ROC-AUCs of the two analy-
ses were compared by evaluating the z-value for paired
scores according to Hanley and McNeil’s formula [Hanley
and McNeil, 1982, 1983] in which the standard error of the
difference between the AUCs is evaluated as function of
their own values and of the correlation between scores.
DA by SVM and the following ROC curve analysis and
accuracy measurements were performed using the Statis-
tics Toolbox of Matlab R2014a (MathWorks, Natick, MA).
The effectiveness of the discrimination in the first stage
of the disease was further explored by excluding the
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Figure 1.
Component maps showing the voxels which contributed most to each component as evaluated
by z-scores. The figure shows the sequence of slides with the spatial maps for the following
components: a) Bilateral cerebellum/midbrain; b) Bilateral medial temporal/sub-genual anterior
cingulate cortex; c) Bilateral parietal/posterior cingulate cortices (posterior portion of DMN); d)
Bilateral motor cortex.
patients with a disease duration< 6 months from the train-
ing set: the model was then fitted using the sample made
up of the patients with longer disease duration along with
controls, while the test was performed on the patients
with short disease duration.
RESULTS
ICA
The optimal number of components was set by GIFT to
18 and all were visually inspected. Ten components
appeared to be noise or scattered small clusters without
any pathophysiological meaning and were discarded. The
remaining 8 components were classified as follows:
1. Bilateral cerebellum/midbrain;
2. Bilateral basal ganglia/thalami;
3. Bilateral temporal cortex;
4. Bilateral frontal/prefrontal cortex;
5. Bilateral parietal/posterior cingulate cortices (poste-
rior portion of DMN);
6. Bilateral medial temporal/sub-genual anterior cingu-
late cortex;
7. Bilateral occipital cortex;
8. Bilateral motor cortex.
When all 8 components were included in the DA the
accuracy in discriminating ALS patients from controls was
99.0% [confidence interval, CI 0.979–1.000] with an AUC of
0.996 [0.965–1.000] and these values remained more or less
constant until the 4 most significant components were
selected by the backward stepwise procedure (bilateral
cerebellum/midbrain; bilateral medial temporal/sub-gen-
ual anterior cingulate cortex; bilateral parietal/posterior
cingulate cortices; bilateral motor cortex) (Figs. 1 and 2).
When only the component corresponding to bilateral cere-
bellum/midbrain was left, the accuracy was still 96.3%
[94.2–98.5] with an AUC of 0.992 [0.973–0.997] (Fig. 2). The
difference between the AUC associated with this best com-
ponent and the AUC associated with the whole set of 8
components was not significant.
Meta-VOIs
The 27 meta-VOIs showed an accuracy of 99.8% [99.0–
100.0] with an AUC of 1.00 [0.998–1.000] until the backward
stepwise procedure identified the 4 most influential regions
(postcentral/precentral gyri/supplementary motor area; left
anterior cingulate cortex; left temporal lobe; and right cere-
bellum) with an accuracy of 99.3% and AUC 0.999 (Fig. 3).
Once the backward stepwise procedure selected only one
meta-VOI (right temporal cortex), the accuracy in discrimi-
nating ALS patients from controls was 93.65% [88.5–94.8]
and the AUC was 0.969 [0.946–0.982] (Fig. 3). The difference
between the AUC associated with this best discriminant
meta-VOI and the AUC associated with the whole set of 27
regions was significant (z5 3.43, P< 0.001).
Comparison Between ICA and meta-VOI
Classification Performance
Considering the very high accuracy consistently
achieved by both the ICA and meta-VOI models when all
or many components or regions were included, the first
comparison made was between the 4-component and the
4-region models obtained by backward stepwise selection.
Figure 2.
Receiver operating characteristic curves expressing classifier per-
formance. Independent-component based classification: optimal
performance is obtained with the four best components and
does not decrease significantly when the single best component
is used.
Figure 3.
Receiver operating characteristic curves expressing classifier per-
formance. Meta-region based classification: optimal performance
is obtained with at least four meta-regions while the performance
slightly but significantly decreases using only the best meta-region.
[Color figure can be viewed in the online issue, which is available
at wileyonlinelibrary.com.]
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The difference in performance between the ICA-based
model (AUC5 0.996) and the meta-VOI-based model
(AUC50.993) was not significant (z5 1.022, N.S.). A sec-
ond comparison was performed in the extreme case of
models including one single feature: in this case the differ-
ence between the ICA-based model (AUC50.992) and the
meta-VOI-based one (AUC5 0.969) was significant
(z5 2.31, P< 0.02).
Discrimination in the Early Stage of the Disease
The previously selected best component was analyzed
in the sample of controls and long disease-duration
patients in order to set the discriminant threshold that was
then applied to the sample of patients in the early stage of
the disease. Out of these 28 early-ALS patients, only one
was undetected (versus 11/299 misclassifications in the
whole sample as tested by ‘leave-one-out’ cross-valida-
tion). When the same procedure was applied using the
previously selected best meta-VOI region, 4 patients were
undetected (versus 25/299 misclassifications).
DISCUSSION
In the present study, we implemented ICA in resting
state FDG-PET to disclose the networks and meta-region
activities characterizing ALS and to assess their possible
diagnostic value. ICA uncovered several spatially distinct
networks that hierarchically showed an extremely high
discriminative value, the cerebellar/midbrain network
being the most accurate (AUC >0.992) in separating ALS
patients from controls. This value was obtained including
in the analysis 259 ALS patients and it exceeded the
already highly significant one found in a previous investi-
gation in which 195 ALS patients were investigated by
FDG-PET showing an AUC of 0.945 [Pagani et al., 2014].
The latter study was performed using 51 VOIs derived
from 65 Brodmann functional areas and all variables were
taken into account in the analysis. In the present investiga-
tion, in order to compare and validate the ICA-based anal-
ysis against an established method, we performed
discriminant analysis on 27 meta-VOIs derived from an
anatomic atlas, AAL, utilizing the same methodology pro-
ven able to discriminate mild cognitive-impaired patients
from healthy controls [Pagani et al., 2015]. The slightly
lower accuracy of the previous ALS study [Pagani et al.,
2014] might be partially due to overfitting (cross-validation
was applied to a smaller sample with a larger number of
VOIs) and partially to the difference in meta-region defini-
tion. In fact, the present choice was consistent with the
nature of the ICs extracted by FDG-PET analysis, in which
disease-specific spatial patterns were evaluated in resting
state condition possibly not superimposing the functional
mapping derived from the segmentation of brain by
means of Brodmann areas.
Resting state interregional correlations reflect neural
interactions occurring when brain activity is not externally
induced or voluntarily generated, yet the subject is cogni-
tively active, mind wandering, meditating or ruminating
during tracer infusion and uptake. Since the brain at rest
contains several functionally discrete networks, intrinsi-
cally organized into covariance patterns, ICA is an ideal
technique since it identifies the underlying activity unique
to each network using data alone without the constraint of
spatial bounds or a priori knowledge [Storti et al., 2013].
In neurodegenerative diseases the interregional correla-
tions of metabolic rates among cross-sectional data of sub-
jects sharing common independent metabolic patterns
indicate the association of spatially connected synaptic
activities affected by common processes and appearing in
two or more regions. This might be of particular relevance
in disorders of the ALS spectrum in which concrete con-
nections between brain regions are certainly affected by
the degeneration of neurons and white matter fibers.
Neurodegenerative processes integrate activity in net-
works rather than in isolated regions, causing brain areas
to reorganize the reciprocal connections. In this respect, in
FDG-PET investigations spatial connectivity representing
the metabolic “signature” of the disease is better captured
by multivariate methods revealing distributed regional
patterns of metabolic integration not shown by the univar-
iate subtraction methods, the latter ignoring inter-regional
metabolic coherence [Toussaint et al., 2012].
Discriminant analysis of the AAL-based meta-VOIs
showed a very high accuracy as well, being still very high
when the most statistically meaningful 4 meta-VOIs were
included in the analysis (AUC5 0.999) and slightly lower
when only one meta-VOI (right temporal) was selected by
the backward stepwise procedure (AUC5 0.969).
Our analysis shows that the main metabolic changes can
also be detected in the early stages of the disease. Consider-
ing the very high accuracy of the method (i.e., few misclas-
sifications) the simplest models (using only one component
or one meta-VOI) were fitted to patients with long disease
duration and then applied to classify the patients with a
disease duration less than 6 months. The simplest models,
in fact, might have given rise to more errors, but the num-
ber of undetected patients was still low.
Besides the outcome of the discriminant analyses, we
were able to reveal by ICA highly concomitant metabolic
activity in sparse networks resulting from the high degree
of interconnectivity across the entire brain. Despite the dif-
ferent origin of the independent spatial components with
respect to the meta-VOIs (data-driven vs. a priori segmen-
tation, respectively) the most discriminant regions selected
by the stepwise backward selection procedure were in
both analyses the cerebellum and the temporal and senso-
rimotor cortices. These regions, showing the most meta-
bolic coherence, were among the ones previously
described to account for the significant differences
between ALS patients and control subjects [Pagani et al.,
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2014; Van Laere et al., 2014] and represent the site where
the neuropathological processes peculiar to the disease
take place.
The component including cerebellum and midbrain
encompasses two regions found in ALS to show changes
in gray [Ellis et al., 2001; Mioshi et al., 2013] and white
[Kassubek et al., 2005] matter volume, fractional anisot-
ropy [Keil et al., 2012; Prell et al., 2013; Prudlo et al., 2012]
and metabolism [Cistaro et al., 2012; Hoffman et al., 1992;
Pagani et al., 2014; Van Laere et al., 2014]. In a previous
FDG-PET study performed on a subset of the present data-
set of ALS patients, these two structures were found to be
relatively hypermetabolic in comparison to controls
[Pagani et al., 2014]. The relative hypermetabolism was
ascribed to a possible excessive presence of activated
astrocytes and microglia, as also described in structural
[Kushner et al., 1991; Philips and Robberecht 2011; Yama-
naka et al., 2008] and functional [Corcia et al., 2012;
Johansson et al., 2007; Turner et al., 2004] studies, resulting
in higher relative FDG uptake than in controls. This has
been considered to be the characteristic metabolic signa-
ture of ALS, and both ICA and meta-VOI analyses con-
firmed the preeminent role of these regions in the
pathophysiology of the disease. Indeed, the cerebellum,
along with the sensorimotor network and DMN, repre-
sented one of the 10 resting state networks described by
Welsh et al. [2013] in the only previous fMRI study imple-
menting ICA and SVM, to discriminate 32 ALS patients
from 31 controls. It showed the possibility of reproducible
and consistent results in ALS research also when different
methods are implemented.
On the other hand, a model of how ALS spreads patho-
logically has recently identified the initial lesions to appear
in the frontal agranular neocortex, somatomotor neurons
of the spinal cord and brainstem diffusing to precerebellar
nuclei of lower brainstem, reticular formation, red nucleus
and eventually to the prefrontal cortex and sensory area to
finally develop in the anterior temporal and hippocampal
cortex [Braak et al., 2013]. This hypothesis of anterograde
propagation from pyramidal cells would support our find-
ings of changes in the corticospinal tracts and the primary
role of somatosensory cortex, midbrain and medial tempo-
ral cortex in ALS pathology.
The sensorimotor cortex has been extensively found by
MRI to be affected in ALS [Chang et al., 2005; Thivard
et al., 2007; Turner et al., 2007] and functional studies have
reported connectivity to be both increased [Agosta et al.,
2013] and decreased [Zhou et al., 2013] in this region. In
keeping with previous findings [Douaud et al., 2011] and
a recent FDG-PET investigation in Alzheimer’s disease
(AD) [Ashraf et al., 2015], in the present study the normal-
ized signal intensity of the bilateral motor cortex compo-
nent was found to be hypermetabolic compared to the
other ICs, and higher in ALS patients than in controls,
suggesting the relative hypermetabolism to be a compen-
satory mechanism to neuronal damage.
A neurophysiological correlate of these findings is the
hyperexcitability of the motor cortex in ALS patients iden-
tified in the early phases of the disease [Geevasinga et al.,
2015] and even preclinically in subjects carrying SOD1
mutations [Vucic et al., 2008]. Interestingly, the hyperexcit-
ability of the motor cortex is specific to ALS when com-
pared to ALS-mimic syndromes [Vucic et al., 2008]. It has
been proposed that this early event is related to a loss of
inhibitory cortical interneurons in motor neuron disease
patients [Nihei et al., 1993] or to a glutamate-mediated
down-regulation of short-interval intracortical inhibition
[Stefan et al., 2001].
The other important component found to play a signifi-
cant role in both ALS-ICA studies was the posterior part
of the default mode network (described as temporoparietal
lobe/posterior cingulate cortex in our study). This region
was found to significantly discriminate mild cognitive-
impaired (MCI) patients converting vs. non converting to
AD both in PET-ICA [Shaffer et al., 2013], PET-PCA
[Nobili et al., 2008] and PET-metaVOIs [Pagani et al., 2015]
investigations. Furthermore, it was one of the ICs that best
predicted conversion from stable to progressing-to-AD
MCI patients [Willette et al., 2014]. In ALS fMRI studies,
enhanced connectivity [Agosta et al., 2013] and decreased
activity [Mohammadi et al., 2009] were reported in this
region with respect to healthy subjects, underscoring its
role in neurodegenerative pathologies, with and without
cognitive impairment.
This posterior portion of the DMN is confirmed to be a
“hub” of functional connectivity coming from distant frontal
and temporal regions and thus largely suffering from synaptic
disconnection, consistently shown by means of FDG-PET,
similarly as happens in AD [Drzezga et al., 2011].
The right temporal cortex in meta-VOI analysis and the
bilateral medial temporal/sub-genual anterior cingulate
cortex along with bilateral cerebellum/midbrain in the
ICA were the regions showing the highest discriminative
value in differentiating ALS patients from controls. In the
present study, we found a relatively higher intensity signal
in these regions compared to the average of the whole
brain. The medial temporal and hippocampal region
showed a significant relative metabolic increase in ALS
patients, as compared to controls [Pagani et al., 2014], and
a significant increase in activated glial cells [Corcia et al.,
2012]. These regions are immediately adjacent to the corti-
cospinal tracts running into the corona radiata and the
smearing of the hypermetabolic PET signal present in
white matter tracts, specific of ALS, might enclose the
most medial part of the temporal and parahippocampal
cortex and be the cause for the voxels composing the ICA
to share similar metabolic coherence.
As compared to previous ICA investigations in ALS and
other neurodegenerative disorders [Toussaint et al., 2012],
the estimates of inter-subject random variability in the
present study were more robust based on the greater num-
ber of subjects, increasing the power of the analysis since
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the sampling error decreases with the increase of sample
size. Moreover, the exploratory analysis of a relatively
large number of regions was supported by the large sam-
ple size, reducing sampling error and overfitting, while
the generalization of findings and effectiveness of classifi-
cation were supported by the “leave-one-out” cross valida-
tion. Further, use of the stepwise backward selection
procedure identified the minimal number of components
(or meta-VOIs) necessary for a suitable group discrimina-
tion focusing on the most distinctive and robust patho-
physiological changes caused by ALS. Cross-correlation
analysis allowed for the discrimination of the pathology at
individual level, paving the way to a clinical application
of the method based on large datasets of patients and
healthy controls in which subjects can be assigned to
either group.
Although an expert system based on predetermined
regions of interest provided a discrimination accuracy
between 97 and 99% using 1 or 4 meta-VOIs, respectively,
the neurophysiological value of the ICA findings cannot
be overlooked. A single component is more representative
than a single meta-VOI since it results from a data-driven
connectivity heavily influenced by the pathophysiology of
the disease. The spatial correlations expressed by the ICs
found in the present study are informative beyond the
pure diagnostic utility of the study. ICA can help to detect
in vivo different patterns of involvement of functional net-
works beyond the “classical” motor system (i.e., primary
motor cortex and pyramidal tracts) and the modality of
spreading of the functional alterations over time. ICs can
also be used to determine the different endophenotypes of
ALS, improving our ability to classify patients for clinical
and trial purposes. In this perspectives, when imple-
mented in neurodegenerative disorders, ICA-derived (or
more generally: multivariately derived) profiles can satisfy
both needs of (i) high diagnostic utility and (ii) mechanis-
tic insight into the etiology of the various diseases.
Pattern-based classification, providing insight into the
nature of neural representation, has a strong potential to
become the standard approach in functional neuroimaging
overcoming the limitations of distinct cortical disease
localization treating voxels as independent units and dis-
carding most of the information potentially gathered by
neuroimaging [O’Toole et al., 2007].
The components defined by the present analysis are
somewhat similar to the ones reported by investigations
on large datasets of resting state studies performed on
healthy controls by fMRI [Kalcher et al., 2012], PET [Marti-
nez-Murcia et al., 2013] or both [Di and Biswal, 2012]. As
compared to those ICs, the ones identified by our analysis
were larger and more symmetric in accordance with the
high correlations found in metabolic studies of homotropic
homologous regions [Horwitz et al., 1984] and encom-
passed regions found to be implicated in ALS pathology.
In fact, among the physiologically meaningful, even if less
discriminant, we identified the bilateral frontal/prefrontal
cortex and occipital cortex, described by previous studies
to be implicated in significant metabolic differences
between ALS patients and controls [Pagani et al., 2014;
Van Laere et al., 2014].
The implementation of the one-class-discrimination
approach, in which the very well-sampled group of
patients served as a training set, isolated the ICs character-
istic of the pathology, connoting the analysis as ALS-
driven and underscoring the differences with respect to
the less homogeneous group of control subjects.
Limitations
Even though the regions included in the same compo-
nent are spatially correlated we cannot exclude that the
extraction of too many or too few components caused
regions not present in the same component to be arbitra-
rily separated by the algorithm [Di and Biswal, 2012].
However low model orders of up to 100 components seem
to be robust and repeatable [Abou-Elseoud et al., 2010].
The analyses did not take into account in this cohort of
ALS patients the possible gray and white matter changes
of volume. Anyhow, the volumetric correction of meta-
bolic data was found to have no impact on the PET data,
the two parameters being dissociated [Di and Biswal,
2012].
One possible drawback of exploratory analyses is that
data were analyzed first and labeled post-hoc subjectively
by visual assessment of the experimenters according to
their pathophysiological interpretability, potentially bias-
ing the results. However, the interpretation of the findings
and the choice of the meaningful components fits with the
known neuropathological features of ALS, confirming, in a
large cohort of patients and by an objective data-driven
method, the involvement in ALS of the brain regions
described by several functional studies [Cistaro et al.,
2012; Lloyd et al., 2000; Pagani et al., 2014; Turner et al.,
2005; Van Laere et al., 2014].
This study investigated only ALS patients without tak-
ing into account other forms of motor neuron disease.
Future studies comparing PET patterns in ALS patients
and in subjects with ALS-mimic syndromes will help us to
better understand whether PET can be of support in the
differential diagnosis of ALS. This will be feasible when
there will be a sufficient number of the latter patients to
guarantee reliable results.
CONCLUSION
This work shows that FDG-PET brain patterns in ALS
are consistently identified by means of ICA, which is not
possible with conventional voxel-based univariate analysis.
The data confirm, in a very large ALS cohort, the capabil-
ity of FDG-PET and ICA to identify the neurodegenerative
features typical of patients, paving the way to a correct
inclusion of ALS patients in clinical trials and early
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diagnosis, as in the past occurred for AD. We have shown
that ICA, networking and multivariate analysis perform
better in comparison to other univariate semi-quantifica-
tion methods. This might be of particular relevance in dis-
orders of the ALS spectrum in which concrete connections
between brain regions are certainly affected by the degen-
eration of neurons and white matter fibers.
In addition, the metabolic network patterns identified in
this study indicate the functional involvement in ALS of
several motor and non-motor areas, including “atypical”
areas such as the cerebellum/midbrain, as well as the
presence of hypermetabolism in the classically involved
area, i.e., the bilateral motor cortex. These latter findings,
which parallel previous neurophysiological findings, could
represent a relevant target for future therapies aimed at
modulating the pathological hyperactivity/hypermetabo-
lism of the motor cortex.
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